KalVista Pharmaceuticals Inc.
KALV | NASDAQ
$27
$0 (0.00%)
Jun 10, 2026, 4:00 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Mar 30, 2026 | Q4 2026 Dec 30, 2025 | Q2 2026 Sep 29, 2025 | Q1 2026 Jul 30, 2025 | Q4 2025 Apr 29, 2025 | Q3 2025 Jan 30, 2025 | Q2 2025 Oct 30, 2024 | Q1 2025 Jul 30, 2024 | Q4 2024 Apr 29, 2024 | Q3 2024 Jan 30, 2024 | Q2 2024 Oct 30, 2023 | Q1 2024 Jul 30, 2023 | Q4 2023 Apr 29, 2023 | Q3 2023 Jan 30, 2023 | Q2 2023 Oct 30, 2022 | Q1 2023 Jul 30, 2022 | Q4 2022 Apr 29, 2022 | Q3 2022 Jan 30, 2022 | Q2 2022 Oct 30, 2021 | Q1 2022 Jul 30, 2021 | Q4 2021 Apr 29, 2021 | Q3 2021 Jan 30, 2021 | Q2 2021 Oct 30, 2020 | Q1 2021 Jul 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 59.93M | -1.43M | 13.69M | 1.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.78M | -1.52M | 1.23M | 590K | 15.89M | n/a | n/a | n/a | 25.25M | 207K | 19.09M | 19.31M | 23.95M | 20.06M | 18.08M | 18.19M | 19.21M | n/a | n/a | n/a | 11.88M | n/a | n/a | n/a |
Gross Profit | 54.15M | 97K | 12.46M | 836K | -15.89M | n/a | n/a | n/a | -25.25M | -207K | -19.09M | -19.31M | -23.95M | -20.06M | -18.08M | -18.19M | -19.21M | n/a | n/a | n/a | -11.88M | n/a | n/a | n/a |
Operating Income | -13.31M | -53.47M | -46.05M | -59.01M | -55.03M | -42.94M | -45.81M | -44.22M | -48.46M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M | -18.04M | -12.66M | -12.78M | -14.44M |
Interest Income | 3.37M | 1.59M | 1.88M | 1.85M | 1.99M | 1.39M | 1.36M | 1.69M | 1.51M | 684K | 776K | 923K | 808K | 732K | 449K | 242K | 268K | 258K | 290K | 274K | 314K | 137K | 193K | 259K |
Pretax Income | -12.47M | -53.68M | -47.33M | -57.94M | -53.08M | -44.26M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.31M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M | -14.96M | -10.05M | -10.43M | -10.81M |
Net Income | -5.37M | -49.34M | -49.48M | -60.1M | -52.23M | -48.51M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.31M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M | -14.96M | -10.05M | -10.43M | -10.81M |
Selling & General & Admin | 61M | 31.54M | 46.52M | 44.68M | 39.14M | 30.35M | 29.2M | 17.6M | 23.21M | 10.42M | 10.66M | 9.79M | 7.78M | 6.88M | 7.81M | 8.13M | 7.6M | 6.95M | 6.06M | 5.85M | 6.17M | 3.56M | 3.63M | 3.28M |
Research & Development | 8.85M | 19.64M | 11.99M | 15.16M | 15.89M | 12.59M | 16.61M | 26.61M | 25.25M | 22.52M | 19.09M | 19.31M | 23.95M | 20.06M | 18.08M | 18.19M | 19.21M | 19.74M | 17.55M | 13.67M | 11.88M | 9.1M | 9.15M | 11.17M |
Other Expenses | -2.39M | 2.39M | n/a | n/a | -15.89M | n/a | n/a | n/a | -25.25M | n/a | -19.09M | -19.31M | -23.95M | -20.06M | -18.08M | -18.19M | -19.21M | n/a | n/a | n/a | -11.88M | n/a | n/a | n/a |
Operating Expenses | 67.46M | 53.57M | 58.51M | 59.85M | 39.14M | 42.94M | 45.81M | 44.22M | 23.21M | 32.94M | 10.66M | 9.79M | 7.78M | 6.88M | 7.81M | 8.13M | 7.6M | 26.68M | 23.6M | 19.52M | 6.17M | 12.66M | 12.78M | 14.44M |
Interest Expense | 8.65M | 2.42M | 4.76M | 3.52M | 2.94M | 2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -207K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 73.24M | 52.04M | 59.74M | 60.44M | 55.03M | 42.94M | 45.81M | 44.22M | 48.46M | 33.15M | 29.75M | 29.09M | 31.73M | 26.95M | 25.88M | 26.32M | 26.81M | 26.68M | 23.6M | 19.52M | 18.04M | 12.66M | 12.78M | 14.44M |
Income Tax Expense | -7.1M | -4.35M | 2.16M | 2.16M | -855K | 4.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 50.54M | 50.9M | 53.88M | 53.5M | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.54M | 24.48M | 24.44M | 24.43M | 22.66M | 17.96M | 17.91M | 17.85M |
Shares Outstanding (Diluted) | 50.54M | 50.9M | 53.88M | 53.5M | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.55M | 24.48M | 24.44M | 24.43M | 23.12M | 17.96M | 17.91M | 17.85M |
EPS (Basic) | -0.11 | -1.08 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.80 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.90 | -0.92 | -0.80 | -0.66 | -0.66 | -0.56 | -0.58 | -0.61 |
EPS (Diluted) | -0.11 | -1.08 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.80 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.90 | -0.92 | -0.80 | -0.66 | -0.65 | -0.56 | -0.58 | -0.61 |
EBITDA | -12.73M | -61.3M | -42.2M | -54.17M | -54.77M | -41.19M | -45.58M | -43.99M | -48.24M | -32.94M | -29.55M | -28.9M | -31.54M | -26.75M | -25.71M | -26.16M | -26.66M | -26.53M | -23.48M | -19.38M | -17.9M | -12.52M | -12.65M | -14.32M |
EBIT | -13.31M | -61.54M | -42.57M | -54.42M | -55.03M | -41.42M | -45.81M | -44.22M | -48.46M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M | -18.04M | -12.66M | -12.78M | -14.44M |
Depreciation & Amortization | 586.5K | 246K | 369K | 252K | 261K | 229K | 227K | 224K | 219K | 207K | 197K | 193K | 188K | 199K | 173K | 158K | 156K | 149K | 127K | 132K | 140K | 136K | 133K | 128K |
Add to Watchlist
Select watchlists to add or remove KALV